The Relationship Between Suspected Adverse Drug Reactions Of HMG-Coa Reductase Inhibitors And Polypharmacology Using A National Registry Approach
Yousaf, H.; Jones, A. M.
Show abstract
AimsThe aim of this study was to explore the suspected adverse drug reaction (ADR) data of five licensed statins in the UK: atorvastatin, fluvastatin, pravastatin, rosuvastatin and simvastatin. A secondary aim was to determine if there was a link between the polypharmacological properties of the statins and their associated muscle-related side effects. MethodsThe chemical database of bioactive molecules with drug-like properties, European Molecular Biology Laboratory (ChEMBL) was used to obtain data on the pharmacological interactions of statins with human proteins. The Medicines and Healthcare products Regulatory Agencys (MHRA) Yellow Card Scheme was used to obtain reports of suspected ADRs from 2018 to 2022. The OpenPrescribing database was used to obtain the prescribing rates for statistical interpretation. ResultsThe study found no significant difference between the statins in causing ADRs across all organ classes (X2, P > .05). Fluvastatin was found to have a higher incidence of ADRs/100,000 Rx across multiple organ classes. ConclusionNo significant difference was found between the suspected ADR incidence of the statins across all organ classes. No evidence of higher intensity statins causing more muscle symptoms than moderate intensity statins was found.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The wide spectrum anti-inflammatory activity of andrographolide in comparison to NSAIDs: a promising therapeutic compound against the cytokine storm 94%
- Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Hydroxychloroquine in Healthy Volunteers 93%
- Adverse drug reactions associated with the use of biological agents 93%
Similar papers in this journal
- A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model 94%
- Investigation on the interaction between nifedipine and ritonavir containing antivirus regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis 92%
- Antihypertensive Medications and COVID-19 Diagnosis and Mortality: Population-based Case-Control Analysis in the United Kingdom 92%
Similar papers in this journal
- Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media 94%
- Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary 92%
- Large-scale empirical identification of candidate comparators for pharmacoepidemiological studies 90%
Similar papers in this journal
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 92%
- Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis 91%
- PBPK modelling of dexamethasone in patients with COVID-19 and liver disease 91%
Similar papers in this journal
- Suspected Adverse Drug Reactions of the Type 2 Antidiabetic Drug Class Dipeptidyl-Peptidase IV inhibitors (DPP4i): Can polypharmacology help explain? 98%
- Declines, and Pronounced Regional Disparities, in Meperidine Use in the United States 92%
- Repurposed medicines: a scan of the non-commercial clinical research landscape 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.